Cizzle Biotechnology Holdings
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.79KN/A-184.11-248.26N/A-4.84-12.96-1.22-4.64-4.04KN/AN/A
Price/Sales ratio
331.76N/A0.000.000.39N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
472.49N/A0.010.03-0.12606.25125.625.131.604.60N/A-0.12
Price/Cash Flow ratio
-4.53KN/A0.15-0.15-0.05-568.44-13.67-4.77-4.84-10.86N/A-0.05
Price/Free Cash Flow ratio
-1.83KN/A-0.04-0.04-0.04-568.44-13.67-3.98-4.84-10.86N/A-0.04
Price/Earnings Growth ratio
N/AN/AN/A12.41N/AN/A0.20-0.000.0540.42N/AN/A
Dividend Yield
0.00%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
37.00%N/A33.16%31.93%60.81%N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-21.35%N/A-26.00%-44.55%-2341.89%N/AN/AN/AN/AN/AN/A-2341.89%
Pretax Profit Margin
-21.86%N/A-26.94%-45.72%-2341.89%N/AN/AN/AN/AN/AN/A-2341.89%
Net Profit Margin
-18.53%N/A-0.00%-0.00%N/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
15.26%N/A18.56%8.12%6.80%0.00%25.16%0.93%5.29%2609.18%N/A0.00%
Return on Assets
-16.96%N/A-0.00%-0.00%N/A-5037.32%-344.44%-339.39%-32.67%-0.10%N/AN/A
Return On Equity
-26.39%N/A-0.00%-0.01%N/A-12516.96%-968.75%-418.35%-34.46%-0.11%N/AN/A
Return on Capital Employed
-30.32%N/A-62.80%-267.98%737.44%-327.40%-956.25%240.76%-36.47%-0.07%N/A-327.40%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A4.65N/A
Quick Ratio
1.030.820.620.460.564.451.554.384.869.103.890.56
Cash ratio
0.400.070.090.010.011.301.444.013.290.773.890.01
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
95.44N/A79.4689.74-1.15KN/AN/AN/AN/AN/AN/A-1.15K
Operating Cycle
95.44N/A79.4689.74-1.15KN/AN/AN/AN/AN/AN/A-1.15K
Days of Payables Outstanding
97.53N/A67.550.85171.71N/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
-2.09N/A11.9088.89-1.32KN/AN/AN/AN/AN/AN/A-1.32K
Debt Ratios
Debt Ratio
0.090.200.18N/AN/AN/AN/AN/AN/AN/A0.04N/A
Debt Equity Ratio
0.140.430.37N/AN/AN/AN/AN/AN/AN/A0.04N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.120.300.27N/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-0.72-0.540.22N/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
1.552.112.054.16-0.402.482.811.231.051.121.04-0.40
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.07N/A0.03-0.04-6.93N/AN/AN/AN/AN/AN/A-6.93
Free Cash Flow / Operating Cash Flow Ratio
2.472.41-3.873.451.34111.1911N/A1
Cash Flow Coverage Ratio
-0.72-0.540.22N/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
-0.72-0.540.22N/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
-2.55%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A